Dr. Michael Milone

Dr. Michael Milone, University of Pennsylvania Health System, USA


Michael Milone is an Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania and the Perelman School of Medicine at the University of Pennsylvania. He is a trained clinical pathologist, blood banker and laboratory toxicologist, and he currently serves as the Associate Director of the Toxicology and Therapeutic Drug Monitoring Laboratory at the Hospital of the University of Pennsylvania. He earned his MD and PhD degrees in 1999 from the University of Medicine and Dentistry of New Jersey. He is a co-inventor of an adoptive T cell immunotherapy approach to treatment of B-cell malignancy using genetically-modified T cells that has shown promising results in phase I clinical trials in adult and pediatric patients with leukemia. Dr. Milone’s research laboratory continues to focus upon adoptive T cell immunotherapy of cancer using CAR-modified T cells alongside efforts to develop improved T cell culture systems.